Testing effectiveness (Phase 2)Looking for participantsNCT05933967
What this trial is testing
Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With Double Expression Diffuse Large B-cell Lymphoma
Who this might be right for
The First Affiliated Hospital of Nanchang University
Shandong Cancer Hospital and Institute 31